Core Viewpoint - The agricultural, animal husbandry, and fishery sector continues to rise, with the only agricultural ETF (159275) showing a slight increase of 0.3% as of the report time, driven by gains in specific stocks within the sector [1][3]. Market Performance - The agricultural ETF (159275) opened with a steady upward trend, maintaining a price increase of 0.3% [1]. - Key stocks in the sector, such as Luo Niu Shan, Shen Nong Seed, and Hainan Rubber, have seen significant gains, with Luo Niu Shan rising over 5% and Shen Nong Seed increasing over 4% [1][2]. Price Trends - The price of live pigs has been declining, leading to losses for breeding companies. As of November 24, the average price of live pigs was 11.6 CNY/kg, down from 12.25 CNY/kg on September 30, marking a decrease of 0.65 CNY/kg [1][4]. - The price of piglets also fell to 21.21 CNY/kg, down 1.01 CNY/kg from 22.22 CNY/kg on September 30 [1]. Industry Outlook - Jiang Hai Securities suggests that due to policy adjustments and production cuts, the industry may experience accelerated capacity reduction, presenting potential investment opportunities in the pig breeding sector [3]. - The agricultural sector is currently at a favorable valuation point, with the agricultural ETF's price-to-book ratio at 2.56, which is at the 28.91% percentile over the past decade, indicating a good long-term investment opportunity [3]. Future Expectations - Zhongyou Securities anticipates that as the deadline for capacity reduction approaches, the pressure on breeding companies will increase, and the industry will continue to face losses, leading to a passive reduction in capacity [4]. - There is an expectation for a new upward trend in pig prices by the second half of next year, driven by various factors including seasonal impacts and policy adjustments [4]. Investment Opportunities - The agricultural ETF (159275) is highlighted as the only ETF tracking the agricultural index, with a significant focus on the pig breeding sector, which constitutes 40.25% of its holdings [5]. - Investors can also consider agricultural ETF linked funds to gain exposure to the agricultural sector [5].

11月18日，路德科技盘中下跌2.02%，截至10:32，报18.93元/股，成交1221.55万元，换手率0.63%，总 市值19.07亿元。 截至9月30日，路德科技股东户数3867.00，较上期减少6.68%；人均流通股26044股，较上期增加 7.16%。2025年1月-9月，路德科技实现营业收入2.54亿元，同比增长14.15%；归母净利润-1612.68万 元，同比减少368.25%。 分红方面，路德科技A股上市后累计派现6118.73万元。近三年，累计派现1510.71万元。 责任编辑：小浪快报 今年以来路德科技已经1次登上龙虎榜，最近一次登上龙虎榜为4月8日，当日龙虎榜净买入732.82万 元；买入总计3861.10万元 ，占总成交额比28.79%；卖出总计3128.28万元 ，占总成交额比23.33%。 资料显示，路德生物环保科技股份有限公司位于湖北省武汉市东湖新技术开发区未来科技城九龙湖街51 号，成立日期2006年8月9日，上市日期2020年9月22日，公司主营业务涉及公司为致力于高含水废弃物 领域技术研发及产业化应用的高新技术企业,专注于河湖淤泥、工程泥浆及工业糟渣等高含水废弃物的 处 ...

11月14日，傲农生物（维权）盘中上涨2.01%，截至13:17，报5.58元/股，成交2.34亿元，换手率 2.69%，总市值145.25亿元。 傲农生物所属申万行业为：农林牧渔-饲料-畜禽饲料。所属概念板块包括：饲料、低价、摘帽概念、猪 肉概念、中盘等。 截至9月30日，傲农生物股东户数7.49万，较上期增加62.69%；人均流通股21340股，较上期减少 38.53%。2025年1月-9月，傲农生物实现营业收入63.35亿元，同比减少8.52%；归母净利润4.14亿元，同 比增长150.54%。 分红方面，傲农生物A股上市后累计派现1.80亿元。近三年，累计派现0.00元。 责任编辑：小浪快报 资金流向方面，主力资金净流出1915.87万元，特大单买入806.52万元，占比3.44%，卖出1721.69万元， 占比7.35%；大单买入3799.71万元，占比16.22%，卖出4800.42万元，占比20.49%。 傲农生物今年以来股价涨57.63%，近5个交易日涨0.72%，近20日涨10.28%，近60日涨53.72%。 今年以来傲农生物已经2次登上龙虎榜，最近一次登上龙虎榜为8月27日，当日龙虎榜净 ...

Core Viewpoint - The stock of Lude Environment has shown a significant increase in price and trading activity, indicating positive market sentiment and potential growth opportunities for the company [1][3]. Group 1: Stock Performance - As of November 13, Lude Environment's stock price rose by 2.04% to 19.51 CNY per share, with a total market capitalization of 1.965 billion CNY [1]. - Year-to-date, the stock has increased by 44.20%, with a slight increase of 1.04% over the last five trading days and a decrease of 7.80% over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 7.3282 million CNY on April 8 [1]. Group 2: Company Overview - Lude Environment, established on August 9, 2006, and listed on September 22, 2020, is based in Wuhan, Hubei Province, focusing on high-water-content waste treatment [2]. - The company specializes in the treatment of high-water-content waste such as river and lake sludge, engineering mud, and industrial residues, utilizing proprietary technologies for efficient waste reduction and resource utilization [2]. - The revenue composition includes 62.51% from bioconversion feed for liquor residue, 16.30% from inorganic solid waste treatment services, and smaller contributions from other waste treatment services [2]. Group 3: Financial Performance - For the period from January to September 2025, Lude Environment reported a revenue of 254 million CNY, reflecting a year-on-year growth of 14.15% [3]. - The company experienced a net loss attributable to shareholders of 16.1268 million CNY, a significant decrease of 368.25% compared to the previous period [3]. - Cumulatively, the company has distributed 61.1873 million CNY in dividends since its A-share listing, with 15.1071 million CNY distributed over the last three years [3].

Core Viewpoint - Jin Xin Nong's stock price has shown significant growth this year, with a notable increase in trading activity and a positive trend in its financial performance despite a decline in net profit [2][3]. Group 1: Stock Performance - As of November 12, Jin Xin Nong's stock price increased by 2.18%, reaching 5.63 CNY per share, with a trading volume of 71.23 million CNY and a turnover rate of 1.61% [1]. - The stock has risen by 41.81% year-to-date, with a 6.23% increase over the last five trading days, 15.84% over the last 20 days, and 34.05% over the last 60 days [2]. Group 2: Financial Overview - For the period from January to September 2025, Jin Xin Nong reported a revenue of 3.541 billion CNY, reflecting a year-on-year growth of 3.04%. However, the net profit attributable to shareholders was -94.22 million CNY, a decrease of 438.06% compared to the previous year [2]. - The company has distributed a total of 368 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Jin Xin Nong was 43,400, a decrease of 13.57% from the previous period, with an average of 18,530 circulating shares per shareholder, an increase of 15.70% [2]. - The second-largest circulating shareholder is Guotai Zhongzheng Livestock Breeding ETF, holding 12.7276 million shares, which is an increase of 4.7225 million shares from the previous period [3].

Core Viewpoint - Jin Xin Nong's stock price has shown significant growth this year, with a year-to-date increase of 39.80% and notable short-term gains in the last 5, 20, and 60 trading days [2] Group 1: Stock Performance - As of November 11, Jin Xin Nong's stock price rose by 2.02% to 5.55 CNY per share, with a trading volume of 84.64 million CNY and a turnover rate of 1.94% [1] - The stock has experienced a net outflow of 7.78 million CNY from main funds, with large orders showing a buy of 17.29 million CNY and a sell of 21.40 million CNY [1] - The stock has been on the "Dragon and Tiger List" once this year, with the last occurrence on April 8 [2] Group 2: Financial Performance - For the period from January to September 2025, Jin Xin Nong reported a revenue of 3.54 billion CNY, reflecting a year-on-year growth of 3.04%, while the net profit attributable to shareholders was a loss of 94.22 million CNY, a decrease of 438.06% [2] - The company has not distributed any dividends in the last three years, with a total payout of 368 million CNY since its A-share listing [3] Group 3: Company Overview - Jin Xin Nong, established on November 6, 1999, and listed on February 18, 2011, is based in Shenzhen, Guangdong Province, specializing in the research, production, and sales of pig feed products [2] - The company's main business revenue composition includes pig compound feed (49.43%), live pigs (32.10%), and other feed products [2] - As of September 30, 2025, the number of shareholders decreased by 13.57% to 43,400, with an average of 18,530 circulating shares per person, an increase of 15.70% [2]

Group 1 - Company plans to raise no more than 3.6 billion yuan through a private placement to fund seven projects, including a 500,000 kW green power project in Inner Mongolia [1] - Company has received acceptance for a clinical trial application for its self-developed drug for metastatic pancreatic ductal adenocarcinoma [1] - Company intends to establish a joint venture to implement a high-quality gallium arsenide chip construction project with a total investment of 272 million yuan [2] Group 2 - Company reported a revenue of 142 million yuan from pig sales in October, with a total sales volume of 162,800 pigs [3] - Company signed an annual procurement contract to supply 870,000 tons of electrolyte products from 2026 to 2028 [5] - Company plans to reduce its shareholding by up to 3% through various trading methods [7] Group 3 - Company intends to purchase 100 hydrogen fuel cell vehicles for a total price of 78.32 million yuan [9] - Company plans to acquire a 51% stake in a semiconductor equipment company for 510 million yuan [10] - Company has regained eligibility to participate in military procurement activities after being removed from the banned list [12] Group 4 - Company plans to establish a joint venture with state-owned funds for rural development with a total registered capital of 2.87 billion yuan [14] - Company reported a revenue of 1.918 billion yuan from pig sales in October, with a significant year-on-year increase [16][17] - Company plans to distribute a cash dividend of 0.01 yuan per share, totaling 7.9801 million yuan [18] Group 5 - Company has submitted an application for H-share listing on the Hong Kong Stock Exchange [19] - Company received approval for its convertible bond issuance application [20] - Company plans to establish a wholly-owned subsidiary with an investment of 70 million yuan focused on innovative medical research [22] Group 6 - Company reported a 33.87% year-on-year increase in sales volume for October [26] - Company has received a product designation from a leading new energy vehicle brand, with an expected total revenue of approximately 470 million yuan [28] - Company has initiated a key Phase III clinical trial for an innovative eye drop treatment for moderate to severe dry eye syndrome [30] Group 7 - Company reported a total automobile sales volume of 170,700 units in October, a year-on-year decrease of 8.1% [30] - Company plans to invest 16 million USD in establishing a production base in Vietnam [33] - Company has received a warning letter from the regulatory authority due to a breach of commitment by its controlling shareholder [52]

Core Viewpoint - TianKang Biological has shown a mixed performance in stock price and financial results, with a notable increase in stock price year-to-date but a decline in net profit for the recent period [1][2]. Group 1: Stock Performance - On November 7, TianKang Biological's stock rose by 2.03%, reaching 7.53 CNY per share, with a trading volume of 80.02 million CNY and a turnover rate of 0.79% [1]. - The stock has increased by 18.96% year-to-date, with a 2.03% rise in the last five trading days, a 2.46% decline over the last 20 days, and a 16.74% increase over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, TianKang Biological reported a revenue of 13.61 billion CNY, representing a year-on-year growth of 4.00%, while the net profit attributable to shareholders decreased by 27.20% to 412 million CNY [2]. - The company has distributed a total of 1.89 billion CNY in dividends since its A-share listing, with 598 million CNY distributed in the last three years [3]. Group 3: Business Overview - TianKang Biological, established on December 28, 2000, and listed on December 26, 2006, is based in Urumqi, Xinjiang, and specializes in the production and sales of biological vaccines for livestock, feed, and plant protein [1]. - The revenue composition of the company includes 32.20% from the pig breeding industry chain, 27.51% from feed, 16.37% from protein and oil processing, 14.75% from corn, 5.44% from veterinary drugs, and 3.40% from other sources [1]. Group 4: Shareholder Information - As of October 31, the number of shareholders for TianKang Biological was 58,000, a decrease of 3.11% from the previous period, with an average of 23,548 circulating shares per shareholder, an increase of 3.21% [2]. - Notable institutional holdings include Guotai Zhongzheng Livestock Breeding ETF as the fifth-largest shareholder with 24.30 million shares, and Hong Kong Central Clearing Limited as the seventh-largest shareholder with 15.03 million shares, marking a new entry [3].

Core Viewpoint - Jin Xin Nong's stock price has shown significant growth this year, with a notable increase in trading activity and a mixed performance in financial results [2][3]. Group 1: Stock Performance - Jin Xin Nong's stock price has increased by 28.21% year-to-date, with a 6.26% rise in the last five trading days, 1.19% in the last 20 days, and 25.68% in the last 60 days [2]. - As of November 5, the stock was trading at 5.09 CNY per share, with a market capitalization of 4.215 billion CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Jin Xin Nong reported revenue of 3.541 billion CNY, reflecting a year-on-year growth of 3.04%. However, the net profit attributable to shareholders was -94.22 million CNY, a decrease of 438.06% compared to the previous year [2]. - The company has not distributed any dividends in the last three years, with a total payout of 368 million CNY since its A-share listing [3]. Group 3: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders decreased by 13.57% to 43,400, while the average circulating shares per person increased by 15.70% to 18,530 shares [2]. - The second-largest circulating shareholder is Guotai Zhongxin Livestock Breeding ETF, holding 12.7276 million shares, an increase of 4.7225 million shares from the previous period [3].

Core Viewpoint - Lude Environment has experienced a stock price increase of 42.50% year-to-date, but recent trading shows a decline in the last 20 and 60 days, indicating potential volatility in the stock performance [1][3]. Company Overview - Lude Environment, established on August 9, 2006, and listed on September 22, 2020, is based in Wuhan, Hubei Province. The company focuses on high-water-content waste treatment, particularly in areas such as river and lake sludge, engineering mud, and industrial residues [2]. - The company utilizes proprietary technologies for waste treatment, including integrated dewatering and solidification of mud and microbial solid-state fermentation of organic residues, aiming for efficient reduction, harmlessness, stabilization, and resource utilization of high-water-content waste [2]. Financial Performance - For the period from January to September 2025, Lude Environment reported a revenue of 254 million yuan, reflecting a year-on-year growth of 14.15%. However, the net profit attributable to shareholders was a loss of 16.13 million yuan, a significant decrease of 368.25% compared to the previous year [3]. - The company has distributed a total of 61.19 million yuan in dividends since its A-share listing, with 15.11 million yuan distributed over the past three years [4]. Shareholder Information - As of September 30, the number of shareholders for Lude Environment was 3,867, a decrease of 6.68% from the previous period. The average number of circulating shares per shareholder increased by 7.16% to 26,044 shares [3].